Sesamin attenuates allergic airway inflammation through the suppression of nuclear factor‑kappa B activation

Li,Liangchang; Piao,Hongmei; Zheng,Mingyu; Jin,Zhewu; Zhao,Liguang; Yan,Guanghai

doi:10.3892/etm.2016.3903

Sesamin attenuates allergic airway inflammation through the suppression of nuclear factor‑kappa B activation

Authors:
- Liangchang Li
- Hongmei Piao
- Mingyu Zheng
- Zhewu Jin
- Liguang Zhao
- Guanghai Yan
View Affiliations

Affiliations: Department of Anatomy, Histology and Embryology, Yanbian University Medical College, Yanji, Jilin 133002, P.R. China, Department of Respiratory Medicine, Yanbian University, Yanji, Jilin 133000, P.R. China, Department of Respiratory Medicine, College of Pharmacy, Yanbian University, Yanji, Jilin 133002, P.R. China
Published online on: November 15, 2016 https://doi.org/10.3892/etm.2016.3903
Pages: 4175-4181

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study is to determine the role of sesamin, the most abundant lignan in sesame seed oil, on the regulation of allergic airway inflammation in a murine asthma model. A BALB/c mouse model with allergic asthma was used to evaluate the effects of sesamin on nuclear factor‑kappa B (NF‑κB) activation. An enzyme‑linked immunosorbent assay was used to determine protein expression in bronchoalveolar lavage (BAL) fluids. Hematoxylin and eosin staining was performed to examine histological changes. Moreover, western blot analysis was used to detect the expression of proteins in tissues. Prior to administering sesamin, the mice developed the following pathophysiological features of asthma: An increase in the number of inflammatory cells, increased levels of interleukin (IL)‑4, IL‑5 and IL‑13, decreased levels of interferon‑γ in BAL fluids and lung tissues, increased immunoglobulin E (IgE) levels in the serum and an increased activation of NF‑κB in lung tissues. Following treatment with sesamin, the mice had evidently reduced peribronchiolar inflammation and airway inflammatory cell recruitment, inhibited production of several cytokines in BAL fluids and lung tissues, and decreased IgE levels. Following inhalation of ovalbumin, the administration of sesamin also inhibited the activation of NF‑κB. In addition, sesamin administration reduced the phosphorylation of p38 mitogen‑activated protein kinases (MAPKs). The present study demonstrates that sesamin decreases the activation of NF‑κB in order to attenuate allergic airway inflammation in a murine model of asthma, possibly via the regulation of phosphorylation of p38 MAPK. These observations provide an important molecular mechanism for the potential use of sesamin in preventing and/or treating asthma, as well as other airway inflammatory disorders.

View Figures

View References

1	Pascual RM and Peters SP: Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol. 116:477–486. 2005. View Article : Google Scholar : PubMed/NCBI
2	Kay AB: Asthma and inflammation. J Allergy Clin Immunol. 87:893–910. 1991. View Article : Google Scholar : PubMed/NCBI
3	Janssen EM, van Oosterhout AJ, van Rensen AJ, van Eden W, Nijkamp FP and Wauben MH: Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: Amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J Immunol. 164:580–588. 2000. View Article : Google Scholar : PubMed/NCBI
4	Mazzarella G, Bianco A, Catena E, De Palma R and Abbate GF: Th1/Th2 lymphocyte polarization in asthma. Allergy. 55:(Suppl 61). S6–S9. 2000. View Article : Google Scholar
5	Primhak RA and Powell CV: AHR in asthma. Thorax. 57:186author reply 186. 2002. View Article : Google Scholar : PubMed/NCBI
6	Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR and Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:298–304. 1992. View Article : Google Scholar : PubMed/NCBI
7	Tournoy KG, Kips JC and Pauwels RA: Is Th1 the solution for Th2 in asthma? Clin Exp Allergy. 32:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
8	Kidd P: Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 8:223–246. 2003.PubMed/NCBI
9	Umetsu DT, McIntire JJ, Akbari O, Macaubas C and DeKruyff RH: Asthma: An epidemic of dysregulated immunity. Nat Immunol. 3:715–720. 2002. View Article : Google Scholar : PubMed/NCBI
10	Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM, Leung BP and Wong WS: A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med. 179:657–665. 2009. View Article : Google Scholar : PubMed/NCBI
11	Janssen-Heininger YM, Poynter ME, Aesif SW, Pantano C, Ather JL, Reynaert NL, Ckless K, Anathy V, van der Velden J, Irvin CG and van der Vliet A: Nuclear factor kappaB, airway epithelium and asthma: Avenues for redox control. Proc Am Thorac Soc. 6:249–255. 2009. View Article : Google Scholar : PubMed/NCBI
12	Tully JE, Hoffman SM, Lahue KG, Nolin JD, Anathy V, Lundblad LK, Daphtary N, Aliyeva M, Black KE, Dixon AE, et al: Epithelial NF-κB orchestrates house dust mite-induced airway inflammation, hyperresponsiveness, and fibrotic remodeling. J Immunol. 191:5811–5821. 2013. View Article : Google Scholar : PubMed/NCBI
13	Ichikawa T, Sugiura H, Koarai A, Kikuchi T, Hiramatsu M, Kawabata H, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, et al: 25-hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-κB dependent pathway. Exp Cell Res. 319:1176–1186. 2013. View Article : Google Scholar : PubMed/NCBI
14	Schieven GL: The biology of p38 kinase: A central role in inflammation. Curr Top Med Chem. 5:921–928. 2005. View Article : Google Scholar : PubMed/NCBI
15	Fu J, Meng X, He J and Gu J: Inhibition of inflammation by a p38 MAP kinase targeted cell permeable peptide. Med Chem. 4:597–604. 2008. View Article : Google Scholar : PubMed/NCBI
16	Saatian B, Zhao Y, He D, Georas SN, Watkins T, Spannhake EW and Natarajan V: Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells. Biochem J. 393:657–668. 2006. View Article : Google Scholar : PubMed/NCBI
17	Saccani S, Pantano S and Natoli G: p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol. 3:69–75. 2002. View Article : Google Scholar : PubMed/NCBI
18	Woo CH, Lim JH and Kim JH: Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol. 173:6973–6980. 2004. View Article : Google Scholar : PubMed/NCBI
19	Nasirullah and Latha RB: Storage stability of sunflower oil with added natural antioxidant concentrate from sesame seed oil. J Oleo Sci. 58:453–459. 2009. View Article : Google Scholar : PubMed/NCBI
20	Yokota T, Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Enoki-Konishi M, Okuyama Y, Takayasu J, Nishino H, Nishikawa A, Osawa T and Sakai T: Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 98:1447–1453. 2007. View Article : Google Scholar : PubMed/NCBI
21	Utsunomiya T, Shimada M, Rikimaru T, Hasegawa H, Yamashita Y, Hamatsu T, Yamasaki M, Kaku S, Yamada K and Sugimachi K: Antioxidant and anti-inflammatory effects of a diet supplemented with sesamin on hepatic ischemia-reperfusion injury in rats. Hepatogastroenterology. 50:1609–1613. 2003.PubMed/NCBI
22	Chavali SR, Zhong WW and Forse RA: Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: Effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids. 58:185–191. 1998. View Article : Google Scholar : PubMed/NCBI
23	Iversen L, Fogh K and Kragballe K: Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: Selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res. 284:222–226. 1992. View Article : Google Scholar : PubMed/NCBI
24	Jeng KC, Hou RC, Wang JC and Ping LI: Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 97:101–106. 2005. View Article : Google Scholar : PubMed/NCBI
25	Phitak T, Pothacharoen P, Settakorn J, Poompimol W, Caterson B and Kongtawelert P: Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry. 80:77–88. 2012. View Article : Google Scholar : PubMed/NCBI
26	Bousquet J, Jeffery PK, Busse WW, Johnson M and Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 161:1720–1745. 2000. View Article : Google Scholar : PubMed/NCBI
27	Wegmann M: Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Rev Mol Diagn. 9:85–100. 2009. View Article : Google Scholar : PubMed/NCBI
28	Holt PG and Sly PD: Th2 cytokines in the asthma late-phase response. Lancet. 370:1396–1398. 2007. View Article : Google Scholar : PubMed/NCBI
29	Siebenlist U, Franzoso G and Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 10:405–455. 1994. View Article : Google Scholar : PubMed/NCBI
30	Baeuerle PA and Baltimore D: NF-kappa B: Ten years after. Cell. 87:13–20. 1996. View Article : Google Scholar : PubMed/NCBI
31	Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol. 14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
32	Barnes PJ: Nuclear factor-kappa B. Int J Biochem Cell Biol. 29:867–870. 1997. View Article : Google Scholar : PubMed/NCBI
33	Ray A, Siegel MD, Prefontaine KE and Ray P: Anti-inflammation: Direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor. Chest. 107:(Suppl 3). S1391995. View Article : Google Scholar
34	Imanifooladi AA, Yazdani S and Nourani MR: The role of nuclear factor-kappaB in inflammatory lung disease. Inflamm Allergy Drug Targets. 9:197–205. 2010. View Article : Google Scholar : PubMed/NCBI
35	Schaeffer HJ and Weber MJ: Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol. 19:2435–2444. 1999. View Article : Google Scholar : PubMed/NCBI
36	Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
37	Han J and Ulevitch RJ: Emerging targets for anti-inflammatory therapy. Nat Cell Biol. 1:E39–E40. 1999. View Article : Google Scholar : PubMed/NCBI
38	Kumar A, Lnu S, Malya R, Barron D, Moore J, Corry DB and Boriek AM: Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: Implications in asthma. FASEB J. 17:1800–1811. 2003. View Article : Google Scholar : PubMed/NCBI
39	Taube C, Nick JA, Siegmund B, Duez C, Takeda K, Rha YH, Park JW, Joetham A, Poch K, Dakhama A, Dinarello CA and Gelfand EW: Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir Cell Mol Biol. 30:837–843. 2004. View Article : Google Scholar : PubMed/NCBI
40	Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, Hay DW and Griswold DE: SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp The. 293:281–288. 2000.
41	Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, Karras JG and Wong WS: Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med. 171:571–578. 2005. View Article : Google Scholar : PubMed/NCBI